پایان نامه رایگان درمورد visited:، the، of، and

دانلود پایان نامه ارشد

Intellectual Property Law Center (MIPLC), 2010.

ج. اسناد سازمان‌ها
61. “Access to essential medicines”, EB134/31, WHO, 14 January 2014.
http://apps.who.int/gb/ebwha/pdf_files/EB134/B134_31-en.pdf, last visited: 05/10/2015.
62. “Access to medicines in the context of the right of everyone to the enjoyment of the highest attainable standard of physical and mental health”, Human Rights Council, A/HRC/23/L.10/Rev.1, United Nations, 11 June 2013.
http://ap.ohchr.org/documents/E/HRC/d_res_dec/A_HRC_23_L10_Rev1.doc, last visited: 05/11/2015.
63. “Amendment of the TRIPS Agreement”, Wt/L/641, WTO, 8 December 2005.
https://www.wto.org/english/tratop_e/trips_e/ta_docs_e/3_wtl641_e.pdf, last visited: 05/07/2015.
64. “Antitrust: Commission enforcement action in pharmaceutical sector following sector inquiry”, European Commission, 2012. & “Antitrust: shortcomings in pharmaceutical sector require further action”, IP/09/1098, Brussels, 2009.
http://europa.eu/rapid/pressReleasesAction.do?reference=MEMO/12/593&format=HTML&aged=0&language=EN&guiLanguage=en, last visited: 10/27/2014.
65. “Bangui Agreement”. Annex I.
http://www.wipo.int/wipolex/en/other_treaties/text.jsp?file_id=181150#P891_63028., last visited: 10/28/2013.
66. “Brazil – Measures Affecting Patent Protection”, Request for Consultations by the United States, WTO, WT/DS199/1, G/L/385, IP/D/23, 8 June 2000.
https://docs.wto.org/dol2fe/Pages/FE_Search/DDFDocuments/35212/Q/G/L/385.pdf, last visited: 10/08/2014.
67. “Brazil – Measures Affecting Patent Protection – Notification of Mutually Agreed Solution”, WTO, WT/DS199/4, G/L/454, IP/D/23/Add.1 19 July 2001.
https://docs.wto.org/dol2fe/Pages/FE_Search/FE_S_S009DP.aspx?language=E&CatalogueIdList=34253&CurrentCatalogueIdIndex=0&FullTextSearch=, last visited: 10/09/2014.
68. “Competition Issues in the Distribution of Pharmaceuticals”. Global Forum on Competition, Contribution from the European Union, Organisation for Economic Co-operation and Development, DAF/COMP/GF/WD(2014)32, 2014.
http://www.oecd.org/officialdocuments/publicdisplaydocumentpdf/?cote=DAF/COMP/GF/WD(2014)32&docLanguage=En, last visited: 10/21/2014.
69. “Competition Issues in the Distribution of Pharmaceuticals”. Global Forum on Competition, Contribution from the European Union, Organisation for Economic Co-operation and Development, DAF/COMP/GF/WD(2014)11, 2014.
70. Constitution of the World Health Organization. Who, 1946.
http://www.who.int/governance/eb/who_constitution_en.pdf, last visited: 09/22/2014.
71. Council Regulation (EC) No. 1383/2003. European Union (EU), 22 July 2003.
http://www.wipo.int/clea/en/details.jsp?id=1455, last visited: 11/24/2014.
72. Declaration of Alma-Ata, international conference on primary heath care, Alma-Ata, USSR, 6-12, September 1978.
http.//www.who.int/publications/almaata-declaration-en.pdf, last visited: 06/07/2014.
73. Declaration of the rights of the child. UN, 1959.
http://www.humanium.org/en/childrens-rights-history/references-on-child-rights/declaration-rights-child/, last visited: 03/06/2015.
74. Declaration on the TRIPS Agreement and Public Health, WT/MIN(01)/DEC/2, 20 Nov. 2001, WTO.
https://www.wto.org/english/thewto_e/minist_e/min01_e/mindecl_trips_e.htm. , last visited: 09/29/2014.
75. European patent convention (EPC). EPO, 1973.
https://www.epo.org/law-practice/legal-texts/archive/epc-1973.html.
76. “European Union and a Member State – Seizure of Generic Drugs in Transit”. Request for Consultations by India, Wt/Ds408/1g/L/921 Ip/D/28, World Trade Organization, 19 May 2010.
http://infojustice.org/download/acta-a2m/government/India%20Request%20for%20Consultation%20(05.19.10).pdf, last visited: 11/24/2014.
77. “Executive Summary of the Discussion on Competition and Generic Pharmaceuticals”. Annex To The Summary Record Of The 121st Meeting Of The Competition Committee Held On 18-19 June 2014, Daf/Comp/M(2014)2/Ann6/Final, Organisation for Economic Co-operation and Development, 10-Feb 2015.
http://www.oecd.org/officialdocuments/publicdisplaydocumentpdf/?cote=DAF/COMP/M(2014)2/ANN6/FINAL&doclanguage=en, last visited: 10/28/2014.
78. “Extension of the Transition Period under Article 66.1 for Least Developed Country Members”. Council for Trade-Related Aspects of Intellectual Property Rights, IP/C/64, WTO, 12 June 2013.
http://www.ipi.gov.mz/IMG/pdf/Decisao_do_Conselho_do_TRIPS_da_OMC_sobre_a_extensao_do_prazo_de_transicao_para_os_PMA.pdf, last visited: 09/30/2014.
79. “Extension of the Transition Period under Article 66.1 for Least-Developed Country Members”, IP/C/40, WTO, 30 November 2005.
http://www.wto.int/english/tratop_e/trips_e/ta_docs_e/7_1_ipc40_e.pdf, last visited: 03/28/2015.
80. “Extension of the Transition Period under Article 66.1 of the TRIPS Agreement for Least-Developed Country Members for Certain Obligations with Respect to Pharmaceutical Products”. IP/C/25, WTO, 1 July 2002.
https://www.wto.org/english/tratop_e/trips_e/art66_1_e.htm, last visited: 03/20/2015.
81. “Feasibility Study on the Disclosure of International Nonproprietary Names (Inn) In Patent Applications and/or Patents”, Scp/21/9, WIPO, September 23, 2014.
http://www.wipo.int/edocs/mdocs/scp/en/scp_21/scp_21_9.pdf, last visited: 05/06/2015.
82. “General Comment No. 14: The Right to the Highest Attainable Standard of Health”. E/C.12/2000/4, UN Committee on Economic, Social and Cultural Rights, 11 August 2000.
http://www.nesri.org/resources/general-comment-no-14-the-right-to-the-highest-attainable-standard-of-health, last visited: 09/23/2014
83. “Generic Pharmaceuticals”. Daf/Comp(2009)39, Organisation For Economic Co-Operation And Development, 2010.
http://www.oecd.org/competition/abuse/46138891.pdf, last visited: 10/25/2014.
84. “Generic Pharmaceuticals”. Note By Chinese Taipei, Daf/Comp/Wd(2014)56, Organisation For Economic Co-Operation And Development, 2014.
http://www.oecd.org/officialdocuments/publicdisplaydocumentpdf/?cote=DAF/COMP/WD(2014)56&docLanguage=En, last visited: 10/30/2014.
85. “Global Report: UNAIDS Report on the Global AIDS Epidemic”. UNAIDS, 2012.
http://www.unaids.org/en/media/unaids/contentassets/documents/epidemiology/2012/gr2012/20121120_UNAIDS_Global_Report_2012_with_annexes_en.pdf, last visited: 03/09/2015.
86. “Global Status Report on Noncommunicable Diseases”. WHO, 2010.
http://whqlibdoc.who.int/publications/2011/9789240686458_eng.pdf, last visited: 03/11/2015.
87. “Globalization, TRIPS and access to pharmaceuticals”. WHO Policy Perspectives on Medicines, No. 3, WHO, Geneva, March 2001.
http://apps.who.int/medicinedocs/pdf/s2240e/s2240e.pdf, last visited: 09/27/2014., last visited: 03/08/2015.
88. “Health intervention and technology assessment in support of universal health coverage”. EB134/30, WHO, 14 January 2014.
http://apps.who.int/gb/ebwha/pdf_files/EB134/B134_30-en.pdf.
89. “Implementation of paragraph 6 of the Doha Declaration on the TRIPS Agreement and public health”. Decision of the General Council of 30 August 2003, Doc.WT/L/540 , WTO, 1 September 2003.
https://www.wto.org/english/tratop_e/trips_e/implem_para6_e.htm, last visited: 09/30/2014.
90. “Indian Supreme Court delivers verdict in Novarits case”. MSF, 1 April 2013.
http://www.msf.org/article/indian-supreme-court-delivers-verdict-novartis-case, last visited: 2015/12/01.
91. International Covenant on Economic, Social and Cultural Rights. Office of the United Nations High Commissioner for Human Rights, 1966.
http://www.ohchr.org/EN/ProfessionalInterest/Pages/CESCR.aspx, last visited: 09/26/2014.
92. “Issue Brief on TRIPS transition period extensions for least-developed countries”. UNDP, UNAIDS, 2013.
http://www.unaids.org/sites/default/files/media_asset/JC2474_TRIPS-transition-period extensions_en_0.pdf, last visited: 10/19/2014.
93. “National Intellectual Property Systems, Innovation and Economic Development”. OECD, 2014.
http://www.oecd.org/sti/inno/ip-innovation-development-main-findings.pdf, last visited: 09/26/2014.
94. Paris Convention for the protection of industrial property. 1883, WIPO.
95. ““Patents and Health: Proposal by the Delegation of the United States Of America”. SCP/17/11, WIPO, December 7, 2011.
http://www.wipo.int/edocs/mdocs/scp/en/scp_17/scp_17_11.pdf
96. “Patent Related Flexibilities in the Multilateral Legal Framework and Their Legislative Implementation at the National and Regional Levels”. CDIP; WIPO, CDIP/5/4, Geneva, 2010.
http://www.wipo.int/edocs/mdocs/mdocs/en/cdip_5/cdip_5_4-main1.pdf, last visited: 10/10/2014.
97. “Patent Related Flexibilities in the Multilateral Legal Framework and their Legislative Implementation at the National and Regional Levels”. WIPO, CDIP/5/4 REV, Annex II, Aug 18, 2010.
http://www.wipo.int/meetings/en/doc_details.jsp?doc_id=142068, last visited: 10/11/2014.
98. “Political Declaration on HIV and AIDS: Intensifying Our Efforts to Eliminate HIV and AIDS”. General Assembly of United Nations, A/RES/65/277, New York, 2011.
http://www.unaids.org/sites/default/files/sub_landing/files/20110610_UN_A-RES-65-277_en.pdf, last visited: 09/26/2014.
99. “Progress report 2011: Global HIV/AIDS response”. UNAIDS; WHO; UNICEF, 2011.
http://www.who. int/hiv/pub/progress_report2011/en/index.html/, last visited: 10/18/2014.
100. “Promotion and Protection of All Human Rights, Civil, Political, Economic, Social and Cultural Rights, Including the Right to Development”. United Nations, A/HRC/11/12, 31 March 2009.
http://www2.ohchr.org/english/bodies/hrcouncil/docs/11session/A.HRC.11.12_en.pdf, last visited: 03/22/2015.
101. “Proposal Submitted By the Delegation of South Africa On Behalf Of the African Group and the Development Agenda Group”. SCP/16/7, WIPO, 2011.
http://www.wipo.int/edocs/mdocs/scp/en/scp_16/scp_16_7.pdf, last visited: 02/19/2015.
102. “Regional issue brief: intellectual property rights and access to medicines”. Global commission on HIV and law; UNDP, South Africa,

پایان نامه
Previous Entries پایان نامه رایگان درمورد مالکیت فکری، سلامت عمومی، حق ثبت اختراع، حقوق مالکیت Next Entries پایان نامه رایگان درمورد حقوق بشر، کپی رایت، شورای حقوق بشر، ایالات متحده آمریکا